Epstein Barr virus (EBV)

As our 20th anniversary year draws to a close, we’re celebrating some of the pioneering women who have contributed to impactful cancer research and paved the way for even more.

Cancer Research UK’s Drug Development Office (DDO) has launched a vaccine trial to treat some forms of cancer caused by the Epstein Barr Virus (EBV).

A vaccine to prevent infection with a common herpes virus, the Epstein-Barr Virus (EBV), could help prevent 200,000 new cancers worldwide per year.